Gene expression of cyclooxygenase-2 group II and cytosolic phospholipase A2 in human colorectal cancer

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3283-3287

  Dimberg, Jan ^a,b   Samuelsson, Anna ^b   Hugander, Anders ^c   Söderkvist, Peter ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b JÖNKÖPING UNIVERSITY   (Sweden)

^c RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

Cyclooxygenase 2; Cytosolic phospholipase A2; Group II phospholigase A2; Human colorectal cancer

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; PHOSPHOLIPASE A2; PROSTAGLANDIN E2;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CYTOSOL; FEMALE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYTOPLASM; FEMALE; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0031730346     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horri A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preisinger AC, Smith KJ, Su L-K, Kinzler KW and Vogelstein B: Mutations of chromosome Sq21 genes in FAP and colorectal cancer patients. Science 253: 665-669, 1991.
2. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N and Dove W: Genetic identification of Mom-1, a major modifier locus affecting Min induced intestinal neoplasia in the mouse. Cell 75: 631-639, 1993.
3. Praml C, Savelyeva L, Le Paslier D, Siracusa LD, Buchberg AM, Schwab M and Amler LC: Human homologue of a candidate for the Moml locus, the secretory type II phospholipse A2(PLA2S-II), maps to 1p35-36.1/D1S199. Cancer Res 55: 5504-5506, 1995.
4. Shoemakef AR, Gould KA, Luongo C, Moser AR and Dove WF: Studies of neoplasia in the Min mouse. Biochem Biophys Acta 1332: F25-F48, 1997.
5. Min induced intestinal neoplasia. Cell 81: 957-966, 1995.
6. Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P, Mulherkar R, Dove WF and Lander ES: Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 17: 88-91, 1997.
7. Seilhammar JJ, Pruzanski W, Vadas P, Plant S, Miller JA, Kloss J and Johnson LK: Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem 264: 5335-5338, 1989.
8. Tomlinson IPM, Neale K, Talbot IC, Spigelman AD, Williams CB, Phillips RKS and Bodmer WF: A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. J Med Genet 33: 268-273, 1996.
9. Verheij HM, Slotboom AJ and de Haas GH: Structure and function of phospholipase A2. Rev Physiol Biochem Pharmacol 91: 91-203, 1981.
10. Mayer RJ and Marshall LA: New insights on mammalian phospholipase A2;comparison of arachidonyl-selective enzymes. FASEB J 7: 339-348, 1993.
11. Dennis EA: Diversity of group types, regulation and function of phospholipase A2. J Biol Chem 269: 13057-13060, 1994.
12. 2+- sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett 410: 49-53, 1997.
13. Mansbach II CM: Phospholipases: Old enzymes with new meaning. Gastroenterology 98: 1369-1382, 1990.
14. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043-1051, 1991.
15. Vadas P, Scott K, Smith G, Rajkovic I, Stefanski E, Scouten B, Singh R and Pruzanski W: Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sci 50: 807-811, 1992.
16. Andersen S, Sjursen W, Volden G and Johansen B: Elevated expression of human nonpancreatic phospholipase A2 inpsoriatic tissue. Inflammation 18: 3-12, 1994.
17. Minami T, Tojo H, Shinomura Y, Tarui S and Okamato M: Raised serum activity of phospholipase A2 immunochemically related to group II in inflammatory bowel disease: its correlation with disease actvity of Chrohn s disease and ulcerative colitis. Gut 33: 914-921, 1992.
18. Minami T, Shinomura Y, Miyagawa J, Tojo H, Okamoto M and Matsuzawa Y: Immunohistochemical localization of group II phospholipase A2 in colonic mucosa of patients with inflammatory bowel disease. Am J Gastroenterol 92: 289-292,1997.
19. Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Kallajoki M and Nevalainen TJ: Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. Gut 40: 95-101, 1997.
20. Hendrickse CW, Radley S, Donovan IA, Keighley MRB and Neoptolemos JP: Activities of phospholipase A2 and diacylglycerol lipase are increased in human colorectal cancer. Br J Surg 82: 475-478, 1995.
21. Heasly LE, Thaler S, Nicks M, Price B, Skorecki K and Nemenoff RA: Induction of cylosolic phospholipase A2 by oncogenic ras in human non-small cell lung cancer. J Biol Chem 272: 14501-14504, 1997.
22. Smith WL: Prostanoid biosynthesis and mechanism of action. Am J Physiol 265: 181-191, 1992.
23. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D and Hwang D: Selective expression of mitogeninducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267; 25934-25938, 1992.
24. O'Neill GP and Ford-Hutchinson AW: Expression of RNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330: 156-160, 1993.
25. DuBois RN and Smalley WE: Cyclooxygenase, NSAIDs and colorectal cancer. J Gastroenterol 31: 898-906, 1996.
26. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp DR and DuBois RN: Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254-2259, 1997.
27. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
28. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M and Hla T: Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-3789, 1995.
29. DuBois RN, Radhika A, Reddy BS and Entingh A: Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262, 1996.
30. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL and Prescott SM: Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci 93: 4816-4820, 1996.
31. Tsujii M, Kawano S and DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci 94: 3336-3340, 1997.
32. Yamaguchi A, Ishida T, Nishimura G, Katoh M and Miyazaki I: Investigation of colonic prostaglandins in carcinogenesis in the rat colon. Dis Colon Rectum 34: 572-576, 1991.
33. Rigas B, Goldman IS and Levine L: Altered eicosanoid levels in human colorectal cancer. J LabClinMed 122: 518-523, 1993.
34. Hendrickse CW, Kelly RW, Radley S, Donovan IA, Keighley MRB and Neoptolemos JP: Lipid peroxidation and prostaglandins in colorectal cancer. Br J Surg 81: 1219-1223, 1994.
35. Riggins GJ, Markowitz S. Wilson JK, Vogelstein B and Kinzler KW: Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res 55: 5184-5186, 1995.
36. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biocheml 62: 156-159, 1987.
37. Nishzuka Y: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308: 639-698, 1984.
38. Dennis EA, Rhee SG, Billah MM and Hannun YA: Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J 5: 2068-2077, 1991.
39. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Taketo MM: Suppression of intestinal polyposis in Ape knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809, 1996.